{"id":"https://openalex.org/W2073973364","doi":"https://doi.org/10.1097/iae.0b013e3182647f69","title":"ASSESSMENT OF THE DIFFERENCES IN PHARMACOKINETICS AND PHARMACODYNAMICS BETWEEN FOUR DISTINCT FORMULATIONS OF TRIAMCINOLONE ACETONIDE","display_name":"ASSESSMENT OF THE DIFFERENCES IN PHARMACOKINETICS AND PHARMACODYNAMICS BETWEEN FOUR DISTINCT FORMULATIONS OF TRIAMCINOLONE ACETONIDE","alternate_titles":[],"publication_year":2012,"publication_date":"2012-09-18","ids":{"openalex":"https://openalex.org/W2073973364","doi":"https://doi.org/10.1097/iae.0b013e3182647f69","mag":"2073973364","pmid":"https://pubmed.ncbi.nlm.nih.gov/22990317"},"language":"en","primary_location":{"id":"doi:10.1097/iae.0b013e3182647f69","doi":"https://doi.org/10.1097/iae.0b013e3182647f69","is_oa":false,"landing_page_url":"https://doi.org/10.1097/iae.0b013e3182647f69","pdf_url":null,"source":{"id":"https://openalex.org/S19572933","display_name":"Retina","issn_l":"0275-004X","issn":["0275-004X","1539-2864"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Retina","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2073973364"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5037034652","display_name":"Leandro Cabral Zacharias","orcid":"https://orcid.org/0000-0003-2965-3315","observed_orcids":["https://orcid.org/0000-0003-2965-3315"]},"institutions":[{"id":"https://openalex.org/I17974374","display_name":"Universidade de S\u00e3o Paulo","ror":"https://ror.org/036rp1748","country_code":"BR","type":"education","lineage":["https://openalex.org/I17974374"]},{"id":"https://openalex.org/I204250578","display_name":"University of California, Irvine","ror":"https://ror.org/04gyf1771","country_code":"US","type":"education","lineage":["https://openalex.org/I204250578"]}],"countries":["BR","US"],"is_corresponding":true,"raw_author_name":"Leandro C. Zacharias","raw_affiliation_strings":["Department of Ophthalmology, Gavin Herbert Eye Institute, University of California Irvine, Irvine, California 92697, USA","Departamento de Oftalmologia, Universidade de S\u00e3o Paulo, S\u00e3o Paulo, Brazil","Department of Ophthalmology, Gavin Herbert Eye Institute, University of California Irvine, Irvine, California"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Ophthalmology, Gavin Herbert Eye Institute, University of California Irvine, Irvine, California 92697, USA","institution_ids":["https://openalex.org/I204250578"]},{"raw_affiliation_string":"Departamento de Oftalmologia, Universidade de S\u00e3o Paulo, S\u00e3o Paulo, Brazil","institution_ids":["https://openalex.org/I17974374"]},{"raw_affiliation_string":"Department of Ophthalmology, Gavin Herbert Eye Institute, University of California Irvine, Irvine, California","institution_ids":["https://openalex.org/I204250578"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5073090222","display_name":"Ton Lin","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ton Lin","raw_affiliation_strings":["Allergan, Inc, Irvine, California"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Allergan, Inc, Irvine, California","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109186663","display_name":"Rafael Migon","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I204250578","display_name":"University of California, Irvine","ror":"https://ror.org/04gyf1771","country_code":"US","type":"education","lineage":["https://openalex.org/I204250578"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Rafael Migon","raw_affiliation_strings":["Department of Ophthalmology, Gavin Herbert Eye Institute, University of California Irvine, Irvine, California"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Ophthalmology, Gavin Herbert Eye Institute, University of California Irvine, Irvine, California","institution_ids":["https://openalex.org/I204250578"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5006820694","display_name":"Corine R. Ghosn","orcid":"https://orcid.org/0000-0003-3268-4374","observed_orcids":["https://orcid.org/0000-0003-3268-4374"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Corine Ghosn","raw_affiliation_strings":["Allergan, Inc, Irvine, California"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Allergan, Inc, Irvine, California","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5066758511","display_name":"Werhner C. Orilla","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Werhner Orilla","raw_affiliation_strings":["Allergan, Inc, Irvine, California"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Allergan, Inc, Irvine, California","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5010044032","display_name":"Barbara Feldmann","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Barbara Feldmann","raw_affiliation_strings":["Allergan, Inc, Irvine, California"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Allergan, Inc, Irvine, California","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5086767791","display_name":"Guadalupe Ru\u00edz","orcid":"https://orcid.org/0000-0003-3761-421X","observed_orcids":["https://orcid.org/0000-0003-3761-421X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Guadalupe Ruiz","raw_affiliation_strings":["Allergan, Inc, Irvine, California"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Allergan, Inc, Irvine, California","institution_ids":[]}]},{"author_position":"middle","author":{"id":null,"display_name":"Yong Li","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Yong Li","raw_affiliation_strings":["Allergan, Inc, Irvine, California"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Allergan, Inc, Irvine, California","institution_ids":[]}]},{"author_position":"middle","author":{"id":null,"display_name":"James Burke","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"James Burke","raw_affiliation_strings":["Allergan, Inc, Irvine, California"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Allergan, Inc, Irvine, California","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5108439897","display_name":"Baruch D. Kuppermann","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I204250578","display_name":"University of California, Irvine","ror":"https://ror.org/04gyf1771","country_code":"US","type":"education","lineage":["https://openalex.org/I204250578"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Baruch D. Kuppermann","raw_affiliation_strings":["Department of Ophthalmology, Gavin Herbert Eye Institute, University of California Irvine, Irvine, California"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Ophthalmology, Gavin Herbert Eye Institute, University of California Irvine, Irvine, California","institution_ids":["https://openalex.org/I204250578"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5037034652","https://openalex.org/A5108439897","https://openalex.org/A5109186663"],"corresponding_institution_ids":["https://openalex.org/I17974374","https://openalex.org/I204250578"],"apc_list":null,"apc_paid":null,"fwci":5.0814,"has_fulltext":false,"cited_by_count":48,"citation_normalized_percentile":{"value":0.95358393,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":99},"biblio":{"volume":"33","issue":"3","first_page":"522","last_page":"531"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10170","display_name":"Retinal Diseases and Treatments","score":0.7910000085830688,"subfield":{"id":"https://openalex.org/subfields/2731","display_name":"Ophthalmology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10170","display_name":"Retinal Diseases and Treatments","score":0.7910000085830688,"subfield":{"id":"https://openalex.org/subfields/2731","display_name":"Ophthalmology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11377","display_name":"Retinal and Macular Surgery","score":0.0544000007212162,"subfield":{"id":"https://openalex.org/subfields/2731","display_name":"Ophthalmology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10920","display_name":"Advanced Drug Delivery Systems","score":0.03889999911189079,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/triamcinolone-acetonide","display_name":"triamcinolone acetonide","score":0.9929999709129333},{"id":"https://openalex.org/keywords/intravitreal-injection","display_name":"intravitreal injection","score":0.8159999847412109},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.7609999775886536},{"id":"https://openalex.org/keywords/pharmacodynamics","display_name":"pharmacodynamics","score":1.0},{"id":"https://openalex.org/keywords/drug-formulation-comparison","display_name":"drug formulation comparison","score":0.6240000128746033},{"id":"https://openalex.org/keywords/kenalog","display_name":"Kenalog","score":0.8790000081062317},{"id":"https://openalex.org/keywords/particle-size","display_name":"particle size","score":0.5529999732971191},{"id":"https://openalex.org/keywords/retinal-vascular-disease","display_name":"retinal vascular disease","score":0.6959999799728394},{"id":"https://openalex.org/keywords/rabbit-model","display_name":"rabbit model","score":0.4180000126361847},{"id":"https://openalex.org/keywords/glaucoma","display_name":"glaucoma","score":0.5450000166893005}],"concepts":[{"id":"https://openalex.org/C2778903070","wikidata":"https://www.wikidata.org/wiki/Q2211240","display_name":"Triamcinolone acetonide","level":2,"score":0.9612202644348145},{"id":"https://openalex.org/C111113717","wikidata":"https://www.wikidata.org/wiki/Q725307","display_name":"Pharmacodynamics","level":3,"score":0.6759620308876038},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.6453373432159424},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5802531242370605},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.41280847787857056},{"id":"https://openalex.org/C118487528","wikidata":"https://www.wikidata.org/wiki/Q161437","display_name":"Ophthalmology","level":1,"score":0.3849859833717346}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001682","descriptor_name":"Biological Availability","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004339","descriptor_name":"Drug Compounding","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005451","descriptor_name":"Fluorescein Angiography","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005938","descriptor_name":"Glucocorticoids","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D005938","descriptor_name":"Glucocorticoids","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D005938","descriptor_name":"Glucocorticoids","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D006207","descriptor_name":"Half-Life","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010316","descriptor_name":"Particle Size","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011310","descriptor_name":"Preservatives, Pharmaceutical","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011817","descriptor_name":"Rabbits","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011994","descriptor_name":"Recombinant Proteins","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012995","descriptor_name":"Solubility","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014222","descriptor_name":"Triamcinolone Acetonide","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D014222","descriptor_name":"Triamcinolone Acetonide","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D014222","descriptor_name":"Triamcinolone Acetonide","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D014822","descriptor_name":"Vitreous Body","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D015861","descriptor_name":"Retinal Neovascularization","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":false},{"descriptor_ui":"D015861","descriptor_name":"Retinal Neovascularization","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D015861","descriptor_name":"Retinal Neovascularization","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":false},{"descriptor_ui":"D042461","descriptor_name":"Vascular Endothelial Growth Factor A","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D042461","descriptor_name":"Vascular Endothelial Growth Factor A","qualifier_ui":"Q000633","qualifier_name":"toxicity","is_major_topic":false},{"descriptor_ui":"D058449","descriptor_name":"Intravitreal Injections","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1097/iae.0b013e3182647f69","doi":"https://doi.org/10.1097/iae.0b013e3182647f69","is_oa":false,"landing_page_url":"https://doi.org/10.1097/iae.0b013e3182647f69","pdf_url":null,"source":{"id":"https://openalex.org/S19572933","display_name":"Retina","issn_l":"0275-004X","issn":["0275-004X","1539-2864"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Retina","raw_type":"journal-article"},{"id":"pmid:22990317","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/22990317","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Retina (Philadelphia, Pa.)","raw_type":"Comparative Study"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9537000060081482,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":42,"referenced_works":["https://openalex.org/W1485105115","https://openalex.org/W1978940806","https://openalex.org/W1980670029","https://openalex.org/W1996474598","https://openalex.org/W1999898983","https://openalex.org/W2002466157","https://openalex.org/W2011515130","https://openalex.org/W2013083252","https://openalex.org/W2017678969","https://openalex.org/W2025947566","https://openalex.org/W2027693928","https://openalex.org/W2029597135","https://openalex.org/W2039243428","https://openalex.org/W2040415931","https://openalex.org/W2044802646","https://openalex.org/W2045042607","https://openalex.org/W2051607881","https://openalex.org/W2054039485","https://openalex.org/W2056288009","https://openalex.org/W2062047918","https://openalex.org/W2064275542","https://openalex.org/W2065262117","https://openalex.org/W2068789854","https://openalex.org/W2070554206","https://openalex.org/W2074123929","https://openalex.org/W2078985232","https://openalex.org/W2079324681","https://openalex.org/W2081647497","https://openalex.org/W2087494096","https://openalex.org/W2087854144","https://openalex.org/W2110309911","https://openalex.org/W2121182991","https://openalex.org/W2134178766","https://openalex.org/W2142697476","https://openalex.org/W2143419021","https://openalex.org/W2146749461","https://openalex.org/W2165265638","https://openalex.org/W2287479431","https://openalex.org/W2546961712","https://openalex.org/W2805868637","https://openalex.org/W2982447704","https://openalex.org/W4229823998"],"related_works":["https://openalex.org/W2025450854","https://openalex.org/W2040415931","https://openalex.org/W2089601340","https://openalex.org/W2002466157","https://openalex.org/W1998875426","https://openalex.org/W2032433709","https://openalex.org/W2009345856","https://openalex.org/W1988398252","https://openalex.org/W2160071288","https://openalex.org/W2333357027"],"abstract_inverted_index":{"In":[0],"Brief":[1],"Purpose:":[2],"To":[3],"compare":[4],"the":[5,105,125,159,167,203,208,231,268,271],"durability":[6],"of":[7,43,98,104,270],"Kenalog,":[8,180],"Trivaris,":[9,132],"Triesence,":[10,137,184],"and":[11,27,65,81,138,185,194,212,221],"compounding":[12],"pharmacy":[13],"preservative-free":[14,144,191],"triamcinolone":[15,46,62,114,145,161,192,224],"acetonide":[16,47,63,115,162,193,198,225],"in":[17],"pigmented":[18],"rabbits":[19,32],"with":[20,41,84,109,219,257],"syneretic":[21],"vitreous":[22,210,236],"using":[23],"direct":[24],"visualization,":[25],"pharmacodynamics,":[26,234],"pharmacokinetics.":[28],"Methods:":[29],"Twenty-five":[30],"Dutch-belted":[31],"were":[33,38,82],"used.":[34],"Pharmacokinetic":[35],"experiment:":[36,60],"Rabbits":[37],"intravitreally":[39],"injected":[40],"one":[42,66],"four":[44],"4-mg":[45],"formulations.":[48,260],"Wide-field":[49],"imaging":[50],"was":[51,107,176],"serially":[52],"performed":[53],"to":[54,87,217,244,264,267],"document":[55],"residual":[56,99],"drug":[57],"mass.":[58],"Pharmacodynamics":[59],"Four":[61],"groups":[64,163],"control":[67],"group":[68],"received":[69],"intravitreal":[70],"recombinant":[71,149],"human":[72,150],"vascular":[73,89,151,246],"endothelial":[74,90,152,247],"growth":[75,91,153,248],"factor":[76,92],"165":[77],"every":[78],"2":[79],"weeks":[80],"followed":[83],"fluorescein":[85],"angiography":[86],"assess":[88],"retinal":[93],"vasculopathy":[94],"as":[95],"a":[96,252],"measure":[97],"steroid":[100],"effect.":[101],"Particle":[102,172,214],"size":[103,173,215,269],"formulations":[106,199,227],"measured":[108],"Mastersizer":[110],"2000.":[111],"Results:":[112],"Remaining":[113],"mass":[116],"after":[117,239],"19":[118],"weeks:":[119],"12,091":[120],"\u00b1":[121,129,134,140],"2,512":[122],"pixels":[123],"for":[124,131,136,142,179,183,188,251],"Kenalog":[126,147,206,242],"group,":[127],"1,307.36":[128],"695.57":[130],"5577":[133],"1477":[135],"1,535":[139],"329":[141],"compounded":[143,190],"acetonide.":[146],"suppressed":[148],"factor\u2013induced":[154,249],"retinopathy":[155,250],"more":[156],"effectively":[157],"than":[158],"other":[160,258],"at":[164],"Week":[165],"39,":[166],"final":[168],"time":[169],"point":[170],"assessed.":[171],"(90th":[174],"percentile)":[175],"47":[177],"\u03bcm":[178,182,187],"26":[181],"22":[186],"both":[189],"Trivaris.":[195],"Conclusion:":[196],"Triamcinolone":[197],"do":[200,228],"not":[201,229],"have":[202],"same":[204,232],"pharmacokinetics/pharmacodynamics.":[205],"has":[207],"longest":[209],"visibility":[211],"durability.":[213,222],"appears":[216],"correlate":[218],"efficacy":[220],"Different":[223],"(TA)":[226],"share":[230],"pharmacokinetics,":[233],"or":[235],"dissolution":[237],"rates":[238],"intravitreous":[240],"injections.":[241],"seems":[243],"suppress":[245],"longer":[253],"period":[254],"when":[255],"compared":[256],"TA":[259,272],"The":[261],"outcomes":[262],"seem":[263],"be":[265],"related":[266],"particles.":[273]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2073973364","counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":4},{"year":2024,"cited_by_count":2},{"year":2023,"cited_by_count":4},{"year":2022,"cited_by_count":2},{"year":2021,"cited_by_count":2},{"year":2020,"cited_by_count":1},{"year":2019,"cited_by_count":5},{"year":2018,"cited_by_count":1},{"year":2017,"cited_by_count":5},{"year":2016,"cited_by_count":3},{"year":2015,"cited_by_count":8},{"year":2014,"cited_by_count":7},{"year":2013,"cited_by_count":3}],"updated_date":"2026-11-07T11:25:07.637180","created_date":"2016-06-24T00:00:00"}
